Home > Insider Trading > Filing (0001209191-15-086355)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326732	Xencor Inc	XNCR	Pharmaceutical Preparations (2834)	201622502

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591213	A Paul Foster	C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-16	5,000	$0.59	9,627	No	4	M	Direct
Common Stock	Disposition	2015-12-16	6,025	$15.01	3,602	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-12-16	5,000	$0.00	5,000	$0.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
53,064		2022-09-25	No	4	M	Direct

Footnotes

Includes 1,207 shares of Common Stock that were acquired by the Reporting Person on June 10, 2015 and 1,212 shares of Common Stock that were acquired by the Reporting Person on December 15, 2015 pursuant to the Issuer's Employee Stock Purchase Plan.
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.
25% of the shares subject to the option shall vest on the one year anniversary of August 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.